CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Virbac SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Virbac SA
13eme rue LID, Bp 27, Carros Cedex
Phone: +33 492087100p:+33 492087100 CARROS, 06510  France Fax: +33 492087165f:+33 492087165
Business Summary
Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. It also offers food and electronic identification chips for pets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairwoman of the Board of Directors Marie-HeleneDick-Madelpuech 58 12/15/2020 4/1/2006
Chief Executive Officer, Member of the Group Executive Committee SebastienHuron 52 12/15/2020
Deputy Chief Executive Officer, Chief Financial Officer, Member of the Group Executive Committee HabibRamdani 47 12/15/2020 1/1/2016
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Sasaeah Pharmaceutical Co.,Ltd. Kamiosaki, 2 Chome-13-2 Shinagawa City Tokyo Japan
Virbac Corporation 1301 Solana Blvd. Westlake TX United States

Business Names
Business Name
0NM7
Alfamed
Animedica SA
63 additional Business Names available in full report.

General Information
Number of Employees: 5,459 (As of 12/31/2023)
Outstanding Shares: 8,369,719 (As of 12/31/2023)
Shareholders: 4,163
Stock Exchange: EPA
Fax Number: +33 492087165


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024